Ventilation Improvements Among K–12 Public School Districts — United States, August–December 2022CDC/MMWR
7 April 2023
Mark-Carew M, Kang G, Pampati S, Mead KR, Martin SB Jr., Barrios LC
To reduce school transmission of SARS-CoV-2, K–12 public school districts implemented various types of ventilation improvements.
Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure (Website, Publication)Journal of Clinical Endocrinology and Metabolism (JCEM)
29 March 2023
Mollie WO, et al.
Infants with in utero COVID-19 exposure vs controls exhibited differential trajectories of weight and BMI.
Updated Assessment on Covid-19 Origins (Document)US Office of the Director of National Intelligence, National Intelligence Council
The IC assesses that SARS-CoV-2, probably emerged and infected humans through an initial small-scale exposure that occurred no later than November 2019 with the first known cluster of COVID-19 cases arising in Wuhan, China in December 2019.
People Who Are Immunocompromised (Website)CDC
Additional info for the immunocompromised: Know how to protect yourself and what to do if you get sick.
COVID-19 Personal Plan (Document)CDC
Tools, information, and action steps to share with your family, friends, and healthcare provider
Notes from the Field: Aircraft Wastewater Surveillance for Early Detection of SARS-CoV-2 Variants — John F. Kennedy International Airport, New York City, August–September 2022 (Website, Publication)CDC/MMWR
24 February 2023
Morfino RC, Bart SM, Franklin A, et al.
Summary from publication: During August 1–September 9, 2022, the biotech company Ginkgo Bioworks, in collaboration with CDC, evaluated the feasibility of SARS-CoV-2 variant detection in aircraft wastewater from incoming international flights.
Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection (Website)JAMA Open Network
14 February 2023
Kwan, A., et.al
Diabetes risk after COVID-19 infection was higher in unvaccinated than vaccinated patients, suggesting a benefit of vaccination.
Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study (Website)The Lancet: Infectious Diseases
13 February 2023
The Lancet: Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. Wong, C., et.al. (Feb 13, 2023)
Wong, C., et.al.
Viral burden rebound rates are similar between patients with antiviral treatment and those without. Importantly, viral burden rebound was not associated with adverse clinical outcomes.
